Liu Xinyang, Ge Xiaoxiao, Zhang Zhe, Zhang Xiaowei, Chang Jinjia, Wu Zheng, Tang Wenbo, Gan Lu, Sun Menghong, Li Jin
Shanghai Medical College, Fudan University, Shanghai, 200032, P.R. China.
Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, P.R. China.
Oncotarget. 2015 Sep 22;6(28):25418-28. doi: 10.18632/oncotarget.4456.
Growing evidence indicates that microRNA (miRNA) plays a vital role in progression and metastasis of gastric cancer (GC). However, the underlying mechanism of miRNA-mediated metastasis has not been fully understood. Recently, miRNA-940 (miR-940) was found to be overexpressed in GC, which correlated with malignant progression and poor survival. Mechanistically, we found that miR-940 promoted GC cell migration, invasion, and metastasis in vivo by directly and functionally repressing the expression of Zinc Finger Transcription Factor 24 (ZNF24). Importantly, upregulation of ZNF24 could re-inhibit miR-940-induced migration and invasion. Hence, we demonstrated the oncogenic role of miR-940 in GC, finding that miR-940 promoted GC progression by directly downregulating ZNF24 expression, and targeting miR-940 could serve as a novel strategy for future GC therapy.
越来越多的证据表明,微小RNA(miRNA)在胃癌(GC)的进展和转移中起着至关重要的作用。然而,miRNA介导转移的潜在机制尚未完全阐明。最近,发现miRNA-940(miR-940)在GC中过表达,这与恶性进展和不良预后相关。机制上,我们发现miR-940通过直接且功能性地抑制锌指转录因子24(ZNF24)的表达来促进GC细胞在体内的迁移、侵袭和转移。重要的是,ZNF24的上调可重新抑制miR-940诱导的迁移和侵袭。因此,我们证明了miR-940在GC中的致癌作用,发现miR-940通过直接下调ZNF24表达促进GC进展,靶向miR-940可作为未来GC治疗的新策略。